XM does not provide services to residents of the United States of America.

HCA Healthcare misses quarterly profit estimates, forecasts up to $300-million hit in Q4



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-HCA Healthcare misses quarterly profit estimates, forecasts up to $300-million hit in Q4</title></head><body>

Adds Q4 expenses and revenue loss in paragraphs 1 and 4, 2025 profit estimates in paragraph 6

Oct 25 (Reuters) - HCA Healthcare HCA.N missed Wall Street estimates for quarterly profit on Friday and forecast up to a $300-million hit in the fourth quarter due to hurricane disruptions, causing its shares to fall 8% in premarket trading.

The hospital operator experienced a loss of revenue in the third quarter owing to the impact of Hurricane Helene on some of its facilities in Florida, Georgia and North Carolina.

Some hospitals delayed procedures because of hurricanes in the past weeks, as well as tight supplies of IV fluid after flooding at a large U.S. facility.

HCA said it expects expenses and loss of revenue of between $200 million and $300 million in the fourth quarter, due to a hit to its facilities from Hurricanes Helene and Milton.

The company had closed five hospitals in Florida earlier this month, in preparation for Hurricane Milton, and transferred about 400 patients from hospitals throughout the state to mandatory evacuation zones.

The hospital operator expects some impact from Hurricane Helene on its North Carolina facilities even next year, but said that would be manageable. It forecast 2025 profit to be near, or slightly above the upper end of its long-term growth range.

HCA posted quarterly revenue of $17.49 billion, missing an estimate of $17.54 billion, according to data compiled by LSEG.

The largest for-profit hospital operator in the United States reported third-quarter profit of $4.88per share. Analysts on average had expecteda profit of $4.97per share.



Reporting by Christy Santhosh in Bengaluru; Editing by Pooja Desai

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.